Low prevalence of Epstein–Barr virus in gastric adenocarcinomas in the UK
Author Information
Author(s): D E Burgess, C B Woodman, K J Flavell, D C Rowlands, J Crocker, K Scott, J P Biddulph, L S Young, P G Murray
Primary Institution: University of Birmingham
Hypothesis
The prevalence of Epstein–Barr virus in gastric adenocarcinomas from the United Kingdom is one of the lowest in the world.
Conclusion
The study found that only 1.7% of gastric adenocarcinomas in the UK were positive for Epstein–Barr virus.
Supporting Evidence
- Only 1.7% of the gastric adenocarcinomas tested positive for Epstein–Barr virus.
- The study included 534 patients diagnosed with gastric adenocarcinoma.
- The mean age of patients was 65.4 years.
- The male to female ratio among participants was 2.2:1.
Takeaway
This study looked at stomach cancer cases in the UK and found that very few had a virus called Epstein–Barr, which is linked to some stomach cancers.
Methodology
The study involved a survey of 534 patients diagnosed with gastric adenocarcinoma, determining EBV status through tissue samples.
Limitations
The study may not represent all gastric adenocarcinomas as it was conducted in a specific region and time frame.
Participant Demographics
The mean age of patients was 65.4 years, with a male to female ratio of 2.2:1.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website